The Type IV Pilin of Burkholderia mallei Is Highly Immunogenic but Fails To Protect against Lethal Aerosol Challenge in a Murine Model

ABSTRACT Burkholderia mallei is the cause of glanders and a proven biological weapon. We identified and purified the type IV pilin protein of this organism to study its potential as a subunit vaccine. We found that purified pilin was highly immunogenic. Furthermore, mice infected via sublethal aerosol challenge developed significant increases in titers of antibody against the pilin, suggesting that it is expressed in vivo. Nevertheless, we found no evidence that high-titer antipilin antisera provided passive protection against a sublethal or lethal aerosol challenge and no evidence of protection afforded by active immunization with purified pilin. These results contrast with the utility of type IV pilin subunit vaccines against other infectious diseases and highlight the need for further efforts to identify protective responses against this pathogen.

[1]  John A Tainer,et al.  Type IV pilus structure by cryo-electron microscopy and crystallography: implications for pilus assembly and functions. , 2006, Molecular cell.

[2]  M. Donnenberg,et al.  Interaction and localization studies of enteropathogenic Escherichia coli type IV bundle-forming pilus outer membrane components. , 2006, Microbiology.

[3]  R. Ulrich,et al.  The Animal Pathogen-Like Type III Secretion System Is Required for the Intracellular Survival of Burkholderia mallei within J774.2 Macrophages , 2006, Infection and Immunity.

[4]  D. Waag,et al.  Monoclonal Antibodies Passively Protect BALB/c Mice against Burkholderia mallei Aerosol Challenge , 2006, Infection and Immunity.

[5]  P. Simpson,et al.  Structure of the Bundle-forming Pilus from Enteropathogenic Escherichia coli* , 2005, Journal of Biological Chemistry.

[6]  I. Beacham,et al.  A Type IV Pilin, PilA, Contributes to Adherence of Burkholderia pseudomallei and Virulence In Vivo , 2005, Infection and Immunity.

[7]  P. Simpson,et al.  Letter to the Editor: Complete Resonance Assignments of Bundlin (BfpA) from the Bundle-forming Pilus of Enteropathogenic Escherichia Coli , 2004 .

[8]  John A. Tainer,et al.  Type IV pilus structure and bacterial pathogenicity , 2004, Nature Reviews Microbiology.

[9]  Luther E. Lindler,et al.  Biological weapons defense: infectious disease and counterbioterrorism. , 2004 .

[10]  P. Simpson,et al.  Complete resonance assignments of bundlin (BfpA) from the bundle-forming pilus of enteropathogenic Escherichia coli. , 2004, Journal of biomolecular NMR.

[11]  J. Hartings,et al.  Impact of Inhalation Exposure Modality and Particle Size on the Respiratory Deposition of Ricin in BALB/c Mice , 2003, Inhalation toxicology.

[12]  D. DeShazer,et al.  Nonviable Burkholderia mallei Induces a Mixed Th1- and Th2-Like Cytokine Response in BALB/c Mice , 2002, Infection and Immunity.

[13]  S. Deitchman,et al.  Glanders in a military research microbiologist. , 2001, The New England journal of medicine.

[14]  R. Hawley,et al.  Biological Weapons—A Primer for Microbiologists , 2001, Annual review of microbiology.

[15]  D. Waag,et al.  In Vitro Antibiotic Susceptibilities ofBurkholderia mallei (Causative Agent of Glanders) Determined by Broth Microdilution and E-Test , 2001, Antimicrobial Agents and Chemotherapy.

[16]  R. Hodges,et al.  The use of synthetic peptides in the design of a consensus sequence vaccine for Pseudomonas aeruginosa. , 2009, The journal of peptide research : official journal of the American Peptide Society.

[17]  M. Wheelis.  First shots fired in biological warfare , 1998, Nature.

[18]  M. Donnenberg,et al.  DsbA is required for stability of the type IV pilin of enteropathogenic Escherichia coli , 1996, Molecular microbiology.

[19]  J. Egerton,et al.  The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK). , 1995, Veterinary microbiology.

[20]  J. Tennent,et al.  The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis. , 1992, Veterinary microbiology.

[21]  J. Seyer,et al.  Localization of protective epitopes within the pilin subunit of the Vibrio cholerae toxin-coregulated pilus , 1991, Infection and immunity.

[22]  P. V. von Hippel,et al.  Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.

[23]  J. Mattick,et al.  Protection of sheep against footrot with a recombinant DNA-based fimbrial vaccine. , 1987, Veterinary microbiology.

[24]  D. Emery,et al.  The protection given by pilus and whole cell vaccines of Bacteroides nodosus strain 198 against ovine foot-rot induced by strains of different serogroups. , 1985, Australian veterinary journal.

[25]  L. Wilkinson.  Glanders: medicine and veterinary medicine in common pursuit of a contagious disease. , 1981, Medical History.

[26]  W. Miller,et al.  Human glanders; report of six cases. , 1947, Annals of internal medicine.

[27]  C. Mcgilvray.  The Transmission of Glanders from Horse to Man. , 1944 .